Search research articles
Contact Us
Filters
Showing results (221-230 of 499) with videos related to
Page
of 50
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer
Jim Cassidy, Josep Tabernero, Chris Twelves, et al.
International Journal of Cancer
|
May 15, 2018
Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
Eric Van Cutsem, Manuel Hidalgo, Jean-Luc Canon, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 2, 2015
Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival
Geert Maleux, Christophe Deroose, Annouschka Laenen, et al.
Future Oncology (London, England)
|
May 10, 2022
MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
Yelena Y Janjigian, Eric Van Cutsem, Kei Muro, et al.
Annals of Surgery
|
October 31, 2007
Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891
Hans G Smeenk, Casper H J van Eijck, Wim C Hop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2012
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial
Eric Van Cutsem, Sanne de Haas, Yoon-Koo Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2008
Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials
Gunnar Folprecht, Matthew T Seymour, Leonard Saltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 17, 2011
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study
Atsushi Ohtsu, Manish A Shah, Eric Van Cutsem, et al.
Future Oncology (London, England)
|
May 9, 2025
A plain language summary of the molecular changes in the tumors of people with BRAF V600E-mutant colorectal cancer in the BEACON study
Scott Kopetz, Danielle A Murphy, Jie Pu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 21, 2018
Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018
Deepak B Vangala, Estelle Cauchin, Judith Balmaña, et al.
Page
of 50
Search research articles
Search
Showing results (221-230 of 499) with videos related to
Sort By:
Page
of 50
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer
Jim Cassidy, Josep Tabernero, Chris Twelves, et al.
International Journal of Cancer
|
May 15, 2018
Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
Eric Van Cutsem, Manuel Hidalgo, Jean-Luc Canon, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 2, 2015
Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival
Geert Maleux, Christophe Deroose, Annouschka Laenen, et al.
Future Oncology (London, England)
|
May 10, 2022
MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
Yelena Y Janjigian, Eric Van Cutsem, Kei Muro, et al.
Annals of Surgery
|
October 31, 2007
Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891
Hans G Smeenk, Casper H J van Eijck, Wim C Hop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2012
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial
Eric Van Cutsem, Sanne de Haas, Yoon-Koo Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2008
Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials
Gunnar Folprecht, Matthew T Seymour, Leonard Saltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 17, 2011
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study
Atsushi Ohtsu, Manish A Shah, Eric Van Cutsem, et al.
Future Oncology (London, England)
|
May 9, 2025
A plain language summary of the molecular changes in the tumors of people with BRAF V600E-mutant colorectal cancer in the BEACON study
Scott Kopetz, Danielle A Murphy, Jie Pu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 21, 2018
Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018
Deepak B Vangala, Estelle Cauchin, Judith Balmaña, et al.
Page
of 50